Stay updated on Pediatric Fremanezumab for Episodic Migraine Clinical Trial

Sign up to get notified when there's something new on the Pediatric Fremanezumab for Episodic Migraine Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Pediatric Fremanezumab for Episodic Migraine Clinical Trial page

  1. Check
    today
    No Change Detected
  2. Check
    yesterday
    No Change Detected
  3. Check
    2 days ago
    Change Detected
    Summary
    The value of Revision has been updated from v2.8.0 to v2.8.1, indicating a recent revision in the content of the webpage.
    Difference
    0.3%
    Check dated 2024-06-13T21:32:22.000Z thumbnail image
  4. Check
    4 days ago
    No Change Detected
  5. Check
    5 days ago
    No Change Detected
  6. Check
    10 days ago
    Change Detected
    Summary
    The value on the webpage has changed from 7 to 8, indicating a recent update in the context of medical and healthcare-related publications and documentation.
    Difference
    0.3%
    Check dated 2024-06-06T14:28:40.000Z thumbnail image
  7. Check
    25 days ago
    Change Detected
    Summary
    The value for the age range in the study 'A Study to Test if Fremanezumab is Effective in Preventing Episodic Migraine in Patients' has been updated from 6 to 7 years. This change likely reflects an adjustment in the eligibility criteria for participants in the clinical trial.
    Difference
    0.3%
    Check dated 2024-05-22T20:53:57.000Z thumbnail image
  8. Check
    46 days ago
    Change Detected
    Difference
    3%
    Check dated 2024-04-30T21:58:58.000Z thumbnail image

Stay in the know with updates to Pediatric Fremanezumab for Episodic Migraine Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Pediatric Fremanezumab for Episodic Migraine Clinical Trial page.